Immunotech Laboratories, Inc. Stock
Stocks
IMMB
US45254F2039
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000200 USD | -.--% |
|
-.--% | +100.00% |
| Market Cap | 6.06M 5.32M 4.89M 4.56M 8.6M 576M 8.78M 58.86M 22.81M 283M 22.74M 22.25M 984M | P/E 2008 * |
-
| P/E 2009 | -310x |
|---|---|---|---|---|---|
| Enterprise Value | 7.25M 6.36M 5.86M 5.46M 10.29M 689M 10.5M 70.44M 27.29M 338M 27.21M 26.62M 1.18B | EV / Sales 2008 * |
-
| EV / Sales 2009 | - |
| Free-Float |
99.34% | Yield 2008 * |
-
| Yield 2009 | - |
| 6 months | +100.00% | ||
| Current year | +100.00% |
| 1 month | 0 |  | 0 |
| Current year | 0 | | 0 |
| 1 year | 0 | | 0 |
| 3 years | 0 | | 0 |
| 5 years | 0 | | 0.01 |
| 10 years | 0 | | 0.09 |
| Manager | Title | Age | Since |
|---|---|---|---|
Harry Zhabilov
PSD | President | 59 | 21/12/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Harry Zhabilov
CHM | Chairman | 59 | 01/07/2014 |
| Director/Board Member | 61 | 04/02/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | +100.00% | -60.00% | 115K | |
| -2.19% | +6.01% | +66.90% | +127.13% | 57.65B | |
| +0.55% | +17.77% | +80.01% | +100.93% | 55.14B | |
| +0.44% | +3.05% | -13.53% | -13.78% | 23.53B | |
| +0.66% | +3.19% | +9.36% | +414.51% | 23.11B | |
| -1.93% | +11.11% | +34.89% | -7.86% | 18.14B | |
| +0.28% | +5.51% | +36.93% | -30.58% | 16.84B | |
| -1.28% | +1.91% | +23.52% | +181.65% | 13.68B | |
| +0.14% | +9.60% | +33.31% | - | 12.97B | |
| -3.56% | +2.27% | +73.68% | +130.90% | 12.38B | |
| Average | -0.70% | +5.00% | +44.51% | +93.66% | 23.34B | |
| Weighted average by Cap. | -0.70% | +4.62% | +47.50% | +116.10% |
| * | 1 * | |
|---|---|---|
| Net sales | - | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
4
- Stock Market
- Stocks
- IMMB Stock
Select your edition
All financial news and data tailored to specific country editions
